Megan M McA'Nulty

Title: The Innovations of Megan M McA'Nulty

Introduction

Megan M McA'Nulty is a notable inventor based in Newton, MA (US). She has made significant contributions to the field of molecular biology, particularly through her work on gene transcription regulation. With a total of 2 patents, her research has implications for understanding and treating various cellular conditions.

Latest Patents

Megan's latest patents focus on a novel mammalian protein known as repressor Kruppel-like factor (RKLF). This zinc finger protein binds to a CACCC element in DNA, effectively repressing gene transcription. The patents disclose an isolated DNA encoding RKLF, along with vectors and cells containing this DNA. Additionally, RKLF-specific antibodies are included in her research. The RKLF DNA or protein can be introduced into mammalian tissues to inhibit neoplasia or hyperplasia. Furthermore, an in vitro screening method for identifying compounds that induce RKLF gene expression is also part of her innovative work.

Career Highlights

Megan is affiliated with Harvard College, where she continues her research and development in the field of molecular biology. Her work has garnered attention for its potential applications in medical science and gene therapy.

Collaborations

Megan collaborates with Mu-En Lee, who is also involved in research related to gene expression and molecular biology.

Conclusion

Megan M McA'Nulty's contributions to the field of molecular biology through her patents on RKLF highlight her innovative spirit and dedication to advancing scientific knowledge. Her work not only enhances our understanding of gene regulation but also opens new avenues for therapeutic interventions.